• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比剂肾病:病例报告及聚焦发病机制的文献综述

Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis.

作者信息

Efstratiadis G, Pateinakis P, Tambakoudis G, Pantzaki A, Economidou D, Memmos D

机构信息

Department of Nephrology, Aristotle University of Thessaloniki, and Department of Pathology, Hippokration General Hospital, Thessaloniki, Greece.

出版信息

Hippokratia. 2008 Apr;12(2):87-93.

PMID:18923657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2464306/
Abstract

Contrast media administration during diagnostic and invasive procedures in high risk patients for nephrotoxicity is a common problem in clinical practice. The mechanisms involved in renal function impairment after contrast media administration are not precisely known but are intensively investigated, and new data have emerged in the literature lately. We present the case of a 72-year old male patient with diabetic nephropathy to whom a new generation iso-osmolar contrast medium (iodixanol) was administered during intravenous pyelography. Due to the contrast agent administration, the patient developed irreversible acute renal failure and became dialysis-dependent. This case suggests that even new generation contrast media (including iodixanol) may be severely nephrotoxic, when administered to high risk patients. Additionally we review the complex mechanisms involved in pathogenesis of contrast media nephrotoxicity.

摘要

在具有肾毒性高风险的患者进行诊断性和侵入性操作期间给予造影剂是临床实践中的常见问题。造影剂给药后肾功能损害所涉及的机制尚不完全清楚,但正在深入研究,最近文献中也出现了新的数据。我们报告一例72岁男性糖尿病肾病患者,在静脉肾盂造影期间给予了新一代等渗造影剂(碘克沙醇)。由于给予造影剂,该患者发生了不可逆的急性肾衰竭并开始依赖透析。该病例表明,即使是新一代造影剂(包括碘克沙醇),给予高风险患者时也可能具有严重肾毒性。此外,我们还综述了造影剂肾毒性发病机制中涉及的复杂机制。

相似文献

1
Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis.对比剂肾病:病例报告及聚焦发病机制的文献综述
Hippokratia. 2008 Apr;12(2):87-93.
2
Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.碘克沙醇与碘海醇在静脉肾盂造影患者中的比较:一项前瞻性对照研究。
Ren Fail. 2009;31(3):181-8. doi: 10.1080/08860220802669636.
3
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.碘克沙醇与碘海醇对慢性肾脏病患者的肾毒性比较:碘克沙醇血管造影/肾功能不全实验室结果干预试验(VALOR)
Am Heart J. 2008 Oct;156(4):776-82. doi: 10.1016/j.ahj.2008.05.023.
4
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.离子型低渗与非离子型等渗对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的比较:ICON(离子型与非离子型对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的研究)。
JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007.
5
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.等渗与低渗对比剂对低风险患者的肾毒性相当。
Clin Nephrol. 2006 Nov;66(5):322-30. doi: 10.5414/cnp66322.
6
Recent clinical trials of iodixanol.碘克沙醇近期的临床试验。
Rev Cardiovasc Med. 2003;4 Suppl 5:S43-50.
7
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.等渗碘克沙醇与非离子型低渗对比剂的肾毒性比较:随机对照试验的荟萃分析
Radiology. 2009 Jan;250(1):68-86. doi: 10.1148/radiol.2501080833.
8
Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.碘克沙醇:在接受诊断性计算机断层扫描检查的伴有潜在肾功能不全的癌症患者中发生对比剂肾病的风险
J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. doi: 10.1097/rct.0b013e31802e29d9.
9
Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.肾功能受损行经皮冠状动脉介入治疗患者的对比剂选择。
Circ Cardiovasc Interv. 2009 Oct;2(5):430-7. doi: 10.1161/CIRCINTERVENTIONS.109.874933. Epub 2009 Sep 22.
10
Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.等渗与低渗对比剂在对比剂诱发肾病高风险门诊患者中的成本效益
Biomedica. 2012 Jun;32(2):182-8. doi: 10.1590/S0120-41572012000300005.

引用本文的文献

1
Evaluation of pathways involved in the protective effect of trans sodium crocetinate against contrast-induced nephropathy in rats.反式藏红花酸钠对大鼠造影剂肾病保护作用相关通路的评估
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5373-5387. doi: 10.1007/s00210-024-03600-y. Epub 2024 Nov 16.

本文引用的文献

1
Contrast-induced nephrotoxicity: clinical landscape.对比剂肾病:临床概况
Kidney Int Suppl. 2006 Apr(100):S3-7. doi: 10.1038/sj.ki.5000366.
2
Contrast-induced nephropathy: a clinical and evidence-based approach.对比剂肾病:一种基于临床与证据的处理方法
Circulation. 2006 Apr 11;113(14):1799-806. doi: 10.1161/CIRCULATIONAHA.105.595090.
3
A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo.A1 腺苷受体基因敲除小鼠在体内对急性放射性造影剂肾病具有保护作用。
Am J Physiol Renal Physiol. 2006 Jun;290(6):F1367-75. doi: 10.1152/ajprenal.00347.2005. Epub 2006 Jan 17.
4
Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art.造影剂肾病发病机制中的光明与阴影:当前进展
Nephrol Dial Transplant. 2005 Aug;20(8):1542-50. doi: 10.1093/ndt/gfh868.
5
Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy.肾脏血流动力学和氧合的区域改变:在造影剂肾病中的作用。
Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i6-11. doi: 10.1093/ndt/gfh1069.
6
Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration.造影剂肾病中的肾血流动力学改变及水化的益处。
Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i2-5. doi: 10.1093/ndt/gfh1066.
7
Contrast-induced nephropathy.对比剂肾病
AJR Am J Roentgenol. 2004 Dec;183(6):1673-89. doi: 10.2214/ajr.183.6.01831673.
8
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.经皮冠状动脉介入治疗后预测对比剂肾病的简单风险评分:开发与初步验证
J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. doi: 10.1016/j.jacc.2004.06.068.
9
[Selection of contrast media for hemodynamic studies and limitation of the associated risk].[用于血流动力学研究的造影剂选择及相关风险的限制]
Ital Heart J Suppl. 2004 Feb;5(2):142-50.
10
Preventing contrast nephropathy: what is the best strategy? A review of the literature.预防对比剂肾病:最佳策略是什么?文献综述
J Clin Pharmacol. 2004 Apr;44(4):327-37. doi: 10.1177/0091270004263466.